Arrested Differentiation, the Self-Renewing Memory Lymphocyte, and Vaccination
- 13 July 2001
- journal article
- review article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 293 (5528) , 248-250
- https://doi.org/10.1126/science.1062589
Abstract
Vaccination for persistent viral or bacterial infections must program the immune system for a lifelong need to generate antigen-specific effector lymphocytes. How the immune system does this is not known, but recent studies have shown that a subset of B lymphocytes, the germinal center B cell, is capable of self-renewal because it expresses a transcriptional repressor, BCL6, that blocks terminal differentiation. If a similar mechanism for arresting differentiation exists for long-lived, antigen-selected lymphocytes, a stem cell–like capacity for self-renewal could be the basis for the continual generation of effector lymphocytes from the memory pool. Understanding how to regulate the terminal differentiation of lymphocytes will improve immunotherapeutic approaches for chronic infectious diseases and cancer.Keywords
This publication has 29 references indexed in Scilit:
- Preferential Localization of Effector Memory Cells in Nonlymphoid TissueScience, 2001
- In vivoandin vitrostudies of immunoglobulin gene somatic hypermutationPhilosophical Transactions Of The Royal Society B-Biological Sciences, 2001
- HIV-Specific Cd8+ T Cells Produce Antiviral Cytokines but Are Impaired in Cytolytic FunctionThe Journal of Experimental Medicine, 2000
- Human Immunodeficiency Virus Type 1- and Cytomegalovirus-Specific Cytotoxic T Lymphocytes Can Persist at High Frequency for Prolonged Periods in the Absence of Circulating Peripheral CD4+T CellsJournal of Virology, 2000
- Two subsets of memory T lymphocytes with distinct homing potentials and effector functionsNature, 1999
- Linear Differentiation of Cytotoxic Effectors into Memory T LymphocytesScience, 1999
- Phenotypic and Functional Separation of Memory and Effector Human CD8+ T CellsThe Journal of Experimental Medicine, 1997
- The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammationNature Genetics, 1997
- Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cellsNature, 1993
- Affinity maturation of antibodiesImmunology Today, 1991